Academia Sinica and vaccine developer Moderna Inc. have agreed to jointly develop messenger ribonucleic acid (mRNA) technology and cultivate research talent in Taiwan under a five-year strategic partnership announced Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Outgoing ambassador positive on Taiwan-Vatican ties under new pope
05/09/2025 12:44 PM - Politics
Taiwan congratulates Leo XIV on being elected new pope
05/09/2025 12:29 PM - Society
KMT Keelung branch chairman detained in recall probe
05/09/2025 10:50 AM - Business
U.S. dollar up in Taipei trading
05/09/2025 10:11 AM - Society
Taiwan headline news
05/09/2025 09:35 AM